Karyopharm Therapeutics
KPTI
KPTI
118 hedge funds and large institutions have $103M invested in Karyopharm Therapeutics in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
-19
Holders Change %
-13.87%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
40
Reduced
29
Closed
35
Calls
$785K
Puts
$182K
Net Calls
+$603K
Net Calls Change
+$232K
Top Buyers
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.25M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$1.61M |
| 3 |
JPMorgan Chase & Co
New York
|
+$1.41M |
| 4 |
Morgan Stanley
New York
|
+$834K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$762K |
